{"id":"https://openalex.org/W19551277","doi":null,"title":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.","display_name":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W19551277","mag":"19551277","pmid":"https://pubmed.ncbi.nlm.nih.gov/18038919"},"language":"en","primary_location":{"id":"pmid:18038919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18038919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112002160","display_name":"Milton D. Rossman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810409","display_name":"Hospital of the University of Pennsylvania","ror":"https://ror.org/02917wp91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799810409","https://openalex.org/I4210143392"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milton D Rossman","raw_affiliation_strings":["Hospital of the University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital of the University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I2799810409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059532507","display_name":"Lee Scott Newman","orcid":"https://orcid.org/0000-0002-8067-1159","observed_orcids":["https://orcid.org/0000-0002-8067-1159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lee S Newman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041237897","display_name":"Robert Phillip Baughman","orcid":"https://orcid.org/0000-0003-4871-3862","observed_orcids":["https://orcid.org/0000-0003-4871-3862"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert P Baughman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075445714","display_name":"Alvin S. Teirstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alvin Teirstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064893377","display_name":"Steven E. Weinberger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven E Weinberger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011910194","display_name":"Wallace T. Miller","orcid":"https://orcid.org/0000-0001-7403-9969","observed_orcids":["https://orcid.org/0000-0001-7403-9969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wallace Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113518348","display_name":"Bruce E Sands","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce E Sands","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6418,"has_fulltext":false,"cited_by_count":166,"citation_normalized_percentile":{"value":0.89061045,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"23","issue":"3","first_page":"201","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pulmonary-sarcoidosis","display_name":"pulmonary sarcoidosis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.5709999799728394},{"id":"https://openalex.org/keywords/vital-capacity","display_name":"vital capacity","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7940000295639038},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.531000018119812},{"id":"https://openalex.org/keywords/tnf-alpha-blockade","display_name":"TNF-alpha blockade","score":0.3479999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9069207906723022},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7904553413391113},{"id":"https://openalex.org/C2781301800","wikidata":"https://www.wikidata.org/wiki/Q193894","display_name":"Sarcoidosis","level":2,"score":0.5757541060447693},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5607974529266357},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5466943979263306},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.5459914803504944},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.535496711730957},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5140470266342163},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42385318875312805},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.060941874980926514},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013147","descriptor_name":"Spirometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013902","descriptor_name":"Radiography, Thoracic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017565","descriptor_name":"Sarcoidosis, Pulmonary","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D017565","descriptor_name":"Sarcoidosis, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:18038919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18038919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG","raw_type":"Journal Article"},{"id":"mag:19551277","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18038919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7097853925","https://openalex.org/W7217788160","https://openalex.org/W7118790830","https://openalex.org/W2767812632","https://openalex.org/W7097846489","https://openalex.org/W2040958678","https://openalex.org/W177723212","https://openalex.org/W2116685057","https://openalex.org/W1522561918","https://openalex.org/W1839661694"],"abstract_inverted_index":{"STUDY":[0],"OBJECTIVES:":[1],"To":[2],"evaluate":[3],"the":[4,11,24,29,119],"safety":[5,204],"and":[6,17,50,74,76,86,110,138,156,170,174,205],"tolerability":[7],"of":[8,13,23,26,31],"infliximab":[9,27,78],"in":[10,28,125,185],"treatment":[12,30],"active":[14,32,52,188],"pulmonary":[15,33,53,168],"sarcoidosis,":[16],"to":[18,60,128,191,201],"provide":[19],"an":[20],"initial":[21],"assessment":[22],"efficacy":[25],"sarcoidosis.":[34],"DESIGN:":[35],"Double-blind,":[36],"randomized,":[37],"placebo-controlled":[38],"phase":[39],"II":[40,144],"study.":[41],"SETTING:":[42],"Multicenter.":[43],"PATIENTS:":[44],"Active":[45],"Radiographic":[46],"Stage":[47],"II,":[48],"III,":[49],"IV":[51],"sarcoidosis":[54],"despite":[55],"corticosteroids":[56],"or":[57,67],"previous":[58],"intolerance":[59],"corticosteroids.":[61],"INTERVENTION:":[62],"Infliximab":[63,181],"5mg/kg":[64,79],"(group":[65,69,108,114],"I)":[66,109],"placebo":[68],"II)":[70],"at":[71,83,101],"weeks":[72,84,118],"0":[73,103],"2":[75],"open-label":[77],"for":[80,134,142],"all":[81],"subjects":[82],"6":[85,117],"14.":[87],"MEASUREMENTS:":[88],"Pulmonary":[89],"function,":[90],"chest":[91],"radiographs,":[92],"dyspnea":[93],"stage,":[94],"SF-36.":[95],"RESULTS:":[96],"Mean":[97],"vital":[98],"capacity":[99],"(VC)":[100],"wk":[102],"was":[104,130],"2.47":[105],"+/-":[106,112,121,132,140],"0.2":[107],"2.37":[111],"0.31":[113],"II).":[115],"At":[116],"mean":[120],"SD":[122],"relative":[123],"change":[124],"VC":[126,184],"compared":[127],"baseline":[129],"15.22":[131],"9.91%":[133],"group":[135,143],"I":[136],"(n=13)":[137],"8.39":[139],"3.33%":[141],"(n=6)":[145],"(p=0.65).":[146],"Four":[147],"patients":[148,186],"had":[149],"serious":[150],"adverse":[151],"events,":[152],"including":[153],"decreased":[154],"WBC":[155],"elevated":[157],"CPK":[158],"(1":[159,162,172,178],"patient),":[160,163,173],"pneumonia":[161],"cellulitis,":[164],"acute":[165],"renal":[166],"failure,":[167],"embolus":[169],"death":[171],"visual":[175],"field":[176],"defect":[177],"patient).":[179],"CONCLUSIONS:":[180],"may":[182],"improve":[183],"with":[187],"PS":[189],"resistant":[190],"steroids.":[192],"Larger":[193],"scale,":[194],"longer":[195],"term":[196],"studies":[197],"will":[198],"be":[199],"needed":[200],"assess":[202],"both":[203],"efficacy.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}